This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 159
of 2 
Show all 159
Data pager
Data pager
12
 Item 1 to 99 of 159
of 2 
Show all 159
Tuesday, January 06 | 3:00PM - 7:00PM
Registration
Room: Longs Foyer


Tuesday, January 06 | 6:15PM - 7:15PM
Refreshments
Room: Longs Foyer


Tuesday, January 06 | 7:15PM - 7:30PM
Orientation
Room: Grays Peak 1-3


Tuesday, January 06 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Grays Peak 1-3

Speaker 1 of 4
* Connie S. Schmaljohn, US Army Medical Research Institute of Infectious Disease, USA

Tuesday, January 06 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Grays Peak 1-3

Speaker 2 of 4
Julie L. Gerberding, Merck & Co., USA
Preparing for 'The New Normal': Innovations in Countermeasures to Combat Public Health Threats

Tuesday, January 06 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Grays Peak 1-3

Speaker 3 of 4
* Margaret A. Liu, ProTherImmune and Karolinska Institutet, USA

Tuesday, January 06 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Grays Peak 1-3

Speaker 4 of 4
Stanley A. Plotkin, Vaxconsult, LLC, USA
Rational Design of Vaccines: Revolution or Evolution?

Wednesday, January 07 | 7:00AM - 8:00AM
Breakfast
Room: Longs Peak


Wednesday, January 07 | 8:00AM - 11:00AM
T Cell Differentiation and Memory; Pathways of Antigen Proc
essing, Co-Stimulation. Session Sponsored in Part by BD Technologies.

Room: Grays Peak 1-2

Speaker 1 of 4
* Peter C. Doherty, University of Melbourne, Australia
Naïve and Memory T Cells in Viral Infections

Wednesday, January 07 | 8:00AM - 11:00AM
T Cell Differentiation and Memory; Pathways of Antigen Proc
essing, Co-Stimulation. Session Sponsored in Part by BD Technologies.

Room: Grays Peak 1-2

Speaker 2 of 4
Susan M. Kaech, The Salk Institute, USA
Pathways of Memory CD8 T Cell Differentiation

Wednesday, January 07 | 8:00AM - 11:00AM
T Cell Differentiation and Memory; Pathways of Antigen Proc
essing, Co-Stimulation. Session Sponsored in Part by BD Technologies.

Room: Grays Peak 1-2

Speaker 3 of 4
Susan L. Swain, University of Massachusetts Medical School, USA
Regulation of CD4 T Cell Memory Generation

Wednesday, January 07 | 8:00AM - 11:00AM
T Cell Differentiation and Memory; Pathways of Antigen Proc
essing, Co-Stimulation. Session Sponsored in Part by BD Technologies.

Room: Grays Peak 1-2

Speaker 4 of 4
Jay A. Berzofsky, NCI, National Institutes of Health, USA
Role of IL-15 in CD8+ T Cell Memory and Avidity Maturation

Wednesday, January 07 | 8:00AM - 11:00AM
Infectious Clone Technology: What Have We Learned So Far?
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 5
* Michael J. Buchmeier, University of California Irvine, USA


Wednesday, January 07 | 8:00AM - 11:00AM
Infectious Clone Technology: What Have We Learned So Far?
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 5
Yoshihiro Kawaoka, University of Wisconsin / University of Tokyo, USA
The Power of Reverse Genetics


Wednesday, January 07 | 8:00AM - 11:00AM
Infectious Clone Technology: What Have We Learned So Far?
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 5
Adolfo García-Sastre, Mount Sinai School of Medicine, USA
Type I Interferon Antagonists of RNA Viruses: Novel Targets for Attenuation in Live Virus Vaccines


Wednesday, January 07 | 8:00AM - 11:00AM
Infectious Clone Technology: What Have We Learned So Far?
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 4 of 5
Juan Carlos de la Torre, The Scripps Research Institute, USA
Arenavirus Reverse Genetics: Implications for Novel Antiviral Strategies


Wednesday, January 07 | 8:00AM - 11:00AM
Infectious Clone Technology: What Have We Learned So Far?
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 5 of 5
Ute Stroeher, Canadian Science Centre for Human and Animal Health, Canada
Reverse Genetics Systems for High-Containment Viruses: Development and Potential Use


Wednesday, January 07 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Foyer


Wednesday, January 07 | 11:00AM - 1:00PM
Poster Setup
Room: Longs Peak


Wednesday, January 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs Peak


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 1 of 9
* John A. Mikszta, BD Technologies, USA

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 2 of 9
* Peter Daddona, Zosano Pharma , Inc., USA

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 3 of 9
Catharine M. Bosio, NIAID, National Institutes of Health, USA
Immunogenicity and Protective Efficacy of Liposome-Based Mucosal Vaccines Against Y. pestis

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 4 of 9
Sophie Chabot, USA
A Novel Intranasal Proteosome-Based Measles Vaccine Induces Neutralizing Antibody Responses in Mice

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 5 of 9
Lakshmi Krishnan, Institute for Biological Sciences, Canada
Delivery of Antigen in Archaeosome Adjuvant Sustains Antigen Presentation and CD8+ CTL Memory in vivo

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 6 of 9
Thomas M. Luby, Abraxis BioScience, USA
Generation of Immune Responses by Immunization with Plasmid DNA Encapsulated in Poly (Lactide-Co-Glycolide) Microparticles is Enhanced by in vivo Electroporation

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 7 of 9
Robert G. Ulrich, Research Institute of Infectious Diseases, USA
Evaluation of New Delivery Devices Targeting the Skin with Recombinant Protein Vaccines

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 8 of 9
Sarah M. Hook, University of Otago, New Zealand
A Formulation Approach to Improving Vaccine Innunogenicity

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Skin and Mucosal Delivery of Vaccines
Room: Grays Peak 1-2

Speaker 9 of 9
James Matriano, ALZA Corporation, USA
A Rapid and Efficient Skin Patch Technology for Vaccine Delivery

Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 8
* Paul F. Bates, University of Pennsylvania School of Medicine, USA


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 8
Andrea F. Bertolotti-Ciarlet, University of Pennsylvania, USA
Cellular Processing and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 8
Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Use of alpha-Dystroglycan as a Receptor by the Arenaviruses


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 4 of 8
David M. Koelle, University of Washington, USA
Intradermal Vaccinia and Skin-Homing T-Cells


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 5 of 8
Mansour Mohamadzadeh, Tulane Medical School, USA
Targeting HCV NS3-NS4A to Dendritic Cells (DC) via DC-Binding Peptides Induces Potent T Cell Immunity in vivo


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 6 of 8
Onesmo Mpanju, U.S. Food and Drug Administration, USA
Identification of Critical Amino Acid Residues on Ebola Virus Glycoprotein Required for Cell Entry


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 7 of 8
Ted C. Pierson, NIAID, National Institutes of Health, USA
Development of Novel Reporter Viruses for the Study of West Nile Virus Entry and its Inhibition


Wednesday, January 07 | 2:00PM - 4:00PM
Workshop 1: Pathogen Receptor Interactions
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 8 of 8
Christopher Premanandan, Ohio State University College of Veterinary Medicine, USA
Interactions of Bacillus anthracis Exotoxins and Cellular Receptors within the Phagolysosome


Wednesday, January 07 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Wednesday, January 07 | 5:00PM - 6:15PM
Genomics and Proteomics: Discovery of Antigens and Immune Mo
dulators (Joint)

Room: Grays Peak 1-2

Speaker 1 of 3
* Margaret A. Liu, ProTherImmune and Karolinska Institutet, USA

Wednesday, January 07 | 5:00PM - 6:15PM
Genomics and Proteomics: Discovery of Antigens and Immune Mo
dulators (Joint)

Room: Grays Peak 1-2

Speaker 2 of 3
Peter L. Andersen, Statens Serum Institut, Denmark
Post genomic insights for the design of TB vaccines for pre- and post-infection administration

Wednesday, January 07 | 5:00PM - 6:15PM
Genomics and Proteomics: Discovery of Antigens and Immune Mo
dulators (Joint)

Room: Grays Peak 1-2

Speaker 3 of 3
Daniel J. Carucci, Foundation for the National Institutes of Health, USA
Identification of Malaria Vaccine Antigens by Proteomics and Incorporation into Molecular Vaccine Development

Wednesday, January 07 | 6:15PM - 7:30PM
Genomic Responses to Infection (Joint)
Room: Grays Peak 1-2

Speaker 1 of 3
* Connie S. Schmaljohn, US Army Medical Research Institute of Infectious Disease, USA

Wednesday, January 07 | 6:15PM - 7:30PM
Genomic Responses to Infection (Joint)
Room: Grays Peak 1-2

Speaker 2 of 3
Alan Aderem, Center for Infectious Disease Research, USA
Large Scale Approaches to Dissecting the Innate Immune Response

Wednesday, January 07 | 6:15PM - 7:30PM
Genomic Responses to Infection (Joint)
Room: Grays Peak 1-2

Speaker 3 of 3
David A. Relman, Stanford University, USA
How the Host Classifies Systemic Infection

Wednesday, January 07 | 7:30PM - 8:30PM
Social Hour
Room: Longs Peak


Wednesday, January 07 | 7:30PM - 10:00PM
Poster Session 1
Room: Longs Peak


Thursday, January 08 | 7:00AM - 8:00AM
Breakfast
Room: Longs Peak


Thursday, January 08 | 8:00AM - 11:00AM
Regulating Immune Responses: New Insights into T Helper Cell
s

Room: Grays Peak 1-2

Speaker 1 of 4
Kevin J. Maloy, University of Oxford, UK
Control of Intestinal Inflammation by Regulatory T Cells

Thursday, January 08 | 8:00AM - 11:00AM
Regulating Immune Responses: New Insights into T Helper Cell
s

Room: Grays Peak 1-2

Speaker 2 of 4
Jeffrey A. Bluestone, University of California, San Francisco, USA
Pathways to Tolerance in Autoimmunity

Thursday, January 08 | 8:00AM - 11:00AM
Regulating Immune Responses: New Insights into T Helper Cell
s

Room: Grays Peak 1-2

Speaker 3 of 4
* Robert A. Seder, NIAID, National Institutes of Health, USA
Distinct Lineages of Th1 Memory Cells have Differential Survival in vivo:
Implications for Vaccine Development Against Diseases Requiring Th1 Responses


Thursday, January 08 | 8:00AM - 11:00AM
Regulating Immune Responses: New Insights into T Helper Cell
s

Room: Grays Peak 1-2

Speaker 4 of 4
Ronald N. Germain, NIAID, National Institutes of Health, USA
Self-Recognition and the Foreign Antigen Sensitivity of Naïve T Cells

Thursday, January 08 | 8:00AM - 11:00AM
New Information on Antiviral Mechanism of Action
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 5
* Robert M. Krug, University of Texas at Austin, USA


Thursday, January 08 | 8:00AM - 11:00AM
New Information on Antiviral Mechanism of Action
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 5
Raul Andino, University of California, San Francisco, USA
The Fine Line Between Genetic Plasticity and Mutagenesis


Thursday, January 08 | 8:00AM - 11:00AM
New Information on Antiviral Mechanism of Action
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 5
Erik De Clercq, Katholieke Universiteit Leuven, Belgium
Therapeutic Potential of Nucleoside/Nucleotide Analogs Against Poxvirus Infections


Thursday, January 08 | 8:00AM - 11:00AM
New Information on Antiviral Mechanism of Action
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 4 of 5
Marc S. Collett, Viropharma, Inc., USA
Antiviral Drugs for Virological Threats of Bioterrorism and Emerging Diseases


Thursday, January 08 | 8:00AM - 11:00AM
New Information on Antiviral Mechanism of Action
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 5 of 5
Karl Y. Hostetler, University of California, San Diego, USA
Synthesis and Evaluation of Orally Active Drugs for Orthopoxvirus Infections


Thursday, January 08 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Foyer


Thursday, January 08 | 11:00AM - 1:00PM
Poster Setup
Room: Longs Peak


Thursday, January 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs Peak


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 1 of 7
Martin Friede, World Health Organization, Switzerland
Aerosol Delivery of Vaccines: The Measles Aerosol Project

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 2 of 7
Yukio Koide, Hamamatsu University School of Medicine, Japan
Induction of Protective Cellular Immunity Against Mycobacterium tuberculosis by Recombinant Attenuated Self-Destructing Listeria monocytogenes Strains Harboring Eukaryotic Expression Plasmids for Ag85 complex and MPB/MPT51

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 3 of 7
Sandra Verhaagh, Crucell Holland BV, Netherlands
Studies Towards an Adenovirus-Based Malaria Vaccine

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 4 of 7
Carmel B. Stober, University of Cambridge, UK
From Genomes to Vaccines for leishmaniasis

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 5 of 7
Erik Rollman, BioArctic, Sweden
HPV-16 L1 Genes with Inactivated Negative RNA Elements Induce Potent Immune Responses

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 6 of 7
Maria J. Gonzalez, The Scripps Research Institute, USA
Induction of T-Cell Immunity by a Plant Virus Vaccine

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Vaccines for Developing Countries: Diseases and
Technologies
Room: Grays Peak 1-2

Speaker 7 of 7
Martin Friede, World Health Organization, Switzerland
Vaccines and Technologies for Resource-Poor Settings

Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 7
* Colleen B. Jonsson, University of Louisville, USA


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 7
Robert M. Krug, University of Texas at Austin, USA
Special Lecture: Novel Targets for Antivirals: The Multiple Functional Domains of the NS1 Proteins of Human Influenza Viruses


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 7
Jeffrey B. Arterburn, New Mexico State University, USA
New Synthetic Nucleoside Antivirals for Hantavirus


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 4 of 7
Frank Alexander Hamill, S.W. Foundation Biomedical Research, USA
Anti-Ebola, Anti-Lassa and Anti-SARS CoV Activity of Antimicrobial Natural Product Chemicals from Rubus apetalus


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 5 of 7
Lisa E. Hensley, NIAID, National Institutes of Health, USA
Evaluation of Interferon-beta as a Therapeutic Treatment for Ebola Hemorrhagic Fever in Nonhuman Primates


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 6 of 7
Benjamin W. Neuman, The Scripps Research Institute, USA
Arenavirus Inside Out: Cryo-EM Structural Studies of Three Arenaviruses


Thursday, January 08 | 2:00PM - 4:00PM
Workshop 2: Novel Approaches to Therapeutics
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 7 of 7
Tibor P. Keler, Celldex Therapeutics, Inc., USA
Development of Fully Human Antibody Against Anthrax Protective Antigen


Thursday, January 08 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Longs Foyer


Thursday, January 08 | 5:00PM - 7:00PM
Innate Immunity: How to Harness or Suppress It
Room: Grays Peak 1-2

Speaker 1 of 4
* Eyal Raz, University of California, San Diego, USA

Thursday, January 08 | 5:00PM - 7:00PM
Innate Immunity: How to Harness or Suppress It
Room: Grays Peak 1-2

Speaker 2 of 4
Peter Aaby, Statens Serum Institut, Denmark
Non-Targeted Effects of Vaccination: Immune Effects and Impact on Additionally Administered Vaccines

Thursday, January 08 | 5:00PM - 7:00PM
Innate Immunity: How to Harness or Suppress It
Room: Grays Peak 1-2

Speaker 3 of 4
Dennis M. Klinman, U.S. Food and Drug Administration, USA
Progress Towards Understanding the Properties of DNA


Thursday, January 08 | 5:00PM - 7:00PM
Innate Immunity: How to Harness or Suppress It
Room: Grays Peak 1-2

Speaker 4 of 4
Heather L. Davis, Pfizer Inc., Canada
Use of CpG TLR9 Agonist as a Vaccine Adjuvant by Parental or Mucosal Routes

Thursday, January 08 | 5:00PM - 7:00PM
Impact of Receptor Binding
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 3
* John A. T. Young, F.Hoffmann-La Roche Ltd, Switzerland
Anthrax Toxin-Receptor Interactions


Thursday, January 08 | 5:00PM - 7:00PM
Impact of Receptor Binding
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 3
Paul F. Bates, University of Pennsylvania School of Medicine, USA
Interaction of Ebola Virus Glycoproteins with Host Factors


Thursday, January 08 | 5:00PM - 7:00PM
Impact of Receptor Binding
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 3
Kathryn V. Holmes, University of Colorado School of Medicine, USA
Determinants of Coronavirus Host Ranges


Thursday, January 08 | 7:00PM - 8:00PM
Social Hour
Room: Longs Peak


Thursday, January 08 | 7:30PM - 10:00PM
Poster Session 2
Room: Longs Peak


Friday, January 09 | 7:00AM - 8:00AM
Breakfast
Room: Longs Peak


Friday, January 09 | 8:00AM - 11:00AM
Delivery Systems and Mucosal Immunization
Room: Grays Peak 1-2

Speaker 1 of 4
Kam W. Leong, Johns Hopkins University in Singapore, Singapore
Formulation and Delivery Aspects of DNA Vaccination

Friday, January 09 | 8:00AM - 11:00AM
Delivery Systems and Mucosal Immunization
Room: Grays Peak 1-2

Speaker 2 of 4
Charles J. Arntzen, Biodesign Institute, Arizona State University, USA
Plant-Derived, Heat-Stable Subunit Vaccines for Oral Immunization

Friday, January 09 | 8:00AM - 11:00AM
Delivery Systems and Mucosal Immunization
Room: Grays Peak 1-2

Speaker 3 of 4
Jean-Marc Balloul, Transgene S.A., France
Antigen + Cytokine Immunotherapy for HPV-Induced Cervical Cancer

Friday, January 09 | 8:00AM - 11:00AM
Delivery Systems and Mucosal Immunization
Room: Grays Peak 1-2

Speaker 4 of 4
Thomas Lehner, Guy's, King's & St. Thomas' Hospital Medical and Dental School, UK
Innate and Adaptive Mucosal Immunity in Protection Against HIV Infection

Friday, January 09 | 8:00AM - 11:00AM
SARS: The First Year
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 1 of 5
* Peter B. Jahrling, National Institutes of Health, USA


Friday, January 09 | 8:00AM - 11:00AM
SARS: The First Year
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 2 of 5
Frank Plummer, Public Health Agency of Canada, Canada
SARS: Lessons Learned in Canada


Friday, January 09 | 8:00AM - 11:00AM
SARS: The First Year
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 3 of 5
Ralph S. Baric, University of North Carolina at Chapel Hill, USA
Reverse Genetics with a Full-Length Infectious cDNA of the Severe Acute Respiratory Disease Syndrome Coronavirus


Friday, January 09 | 8:00AM - 11:00AM
SARS: The First Year
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 4 of 5
Thomas G. Ksiazek, Centers for Disease Control, USA
Identification of a New Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS)


Friday, January 09 | 8:00AM - 11:00AM
SARS: The First Year
This session is from Bioterrorism
Room: Grays Peak 3

Speaker 5 of 5
Mark R. Denison, Vanderbilt University Medical Center, USA
SARS Coronavirus Genetics and Replication


Friday, January 09 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Foyer


Friday, January 09 | 11:00AM - 1:00PM
Poster Setup
Room: Longs Peak


Friday, January 09 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs Peak


Friday, January 09 | 2:00PM - 4:00PM
Workshop 3: Mixed-Modality Vaccines, and Vaccines that Targe
t Dendritic Cells
Room: Grays Peak 1-2

Speaker 1 of 8
* Liisa K. Selin, University of Massachusetts Medical School, USA
The Significance of Heterologous Immunity for Mixed Modality Vaccines

Friday, January 09 | 2:00PM - 4:00PM
Workshop 3: Mixed-Modality Vaccines, and Vaccines that Targe
t Dendritic Cells
Room: Grays Peak 1-2

Speaker 2 of 8
Claire L. Hutchings, University of Oxford, UK
Novel Immunization Strategies using DNA, Poxvirus and Protein Demonstrate a Widely Applicable Method for Simultaneous Induction of Potent Cellular and Humoral Immunity to the Co-Administered Protein and Encoded Antigen

Friday, January 09 | 2:00PM - 4:00PM
Workshop 3: Mixed-Modality Vaccines, and Vaccines that Targe
t Dendritic Cells
Room: Grays Peak 1-2

Speaker 3 of 8
Anne C. Moore, University College Cork, Ireland
Pre-Existing Fowlpox Immunity is Less Inhibitory to Heterologous Prime-Boost Vaccine Strategies Compared to Anti-MVA Immunity

No content found

No content found

No content found